Health will finance PrEP, which is more effective than 90%

Medical societies and NGOs have been requesting implementation for some time

GAYLES.TV.- In the 2015 World Health Organization (WHO) recommended the use of pre-exposure prophylaxis (PrEP), also known as a preventive AIDS pill for people at risk of contracting the virus. One year later it was approved by the European Medicines Agency (EMA). Since then different groups and organizations denounced the delay of their inclusion in Spanish health. It has not been until now when Health has approved the inclusion of this pill in the portfolio of basic Social Security services.

The treatment takes from 2012 in use in the United States and It has an efficiency greater than 90%. "There is plenty of scientific evidence that the PrEP prevents the acquisition of HIV" has declared Julia of the Master, director of the Secretariat of the National AIDS Plan. This inclusion in public financing is another step in the fight against discrimination associated with AIDS.

La PrEP It is a combination of two medicines - tenofovir and emtricitabine - which, consumed daily, prevents people without the virus from contracting HIV. The preventive AIDS pill protects against infection even if sex without a condom is practiced and is indicated in risk groups. Many people turned to PrEP from online pages by self-medicating. Financing by the Health Ministry will imply greater control of people who use this drug in addition to economic relief.